Literature DB >> 24771047

Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.

Mohammed A Aleskandarany1, Ola H Negm, Andrew R Green, Mohamed A H Ahmed, Christopher C Nolan, Patrick J Tighe, Ian O Ellis, Emad A Rakha.   

Abstract

Epithelial mesenchymal transition (EMT), as defined by loss of epithelial characteristics and gain of a mesenchymal phenotype, has been reported in vivo although the occurrence of events remains unclear. This study aims at exploration of EMT portraits of breast cancer (BC) with relevance to different molecular pathways, especially potential EMT triggers and BC molecular subtypes. Immunohistochemical (IHC) expression of markers/triggers of EMT was studied on a well-defined cohort of invasive non-lobular BC (n = 1,035), prepared as tissue microarrays. IHC panel of biomarkers included cadherins (cad; E-cad and N-cad), TGFβ1, PIK3CA, pAkt, and others. Reverse phase protein array (RPPA) was performed for quantitative analysis of proteins extracted from formalin fixed paraffin embedded tissues of a subset of cases from this cohort. Four combinatorial phenotypic groups representing cadherin switch were defined, including E-cad(+)/N-cad(-), E-cad(-)/N-cad(-), E-cad(+)/N-cad(+), and E-cad(-)/N-cad(+). Statistically significant association was noticed between these phenotypes and histological tumour grade, tumour type and size and NPI staging classes. The E-cad/N-cad switch occurred more frequently in the triple negative molecular class, both basal and non-basal, and in the HER2(+) subtype than in luminal BC. Significant outcome differences were observed between cadherin switch combinatorial groups regarding BCSS and DMFS (p < 0.001). Results of RPPA confirm those observed using IHC regarding differential expressions of EMT markers/triggers. EMT/cadherin switch programs in BC appear to occur in synergy with TGFβ1 and PIK3/Akt pathways activation. These data explain, at translational proteomic level, the molecular heterogeneity and in turn the varied clinical behaviour of BC molecular subtypes. RPPA is a promising high-throughput technique in monitoring subtle quantitative changes in protein expression in archival material.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24771047     DOI: 10.1007/s10549-014-2927-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

Review 1.  Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.

Authors:  Xin Ye; Robert A Weinberg
Journal:  Trends Cell Biol       Date:  2015-10-01       Impact factor: 20.808

2.  Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment.

Authors:  Francesc Font-Clos; Stefano Zapperi; Caterina A M La Porta
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  The Predictive Link between Matrix and Metastasis.

Authors:  L E Barney; L E Jansen; S R Polio; S Galarza; M E Lynch; S R Peyton
Journal:  Curr Opin Chem Eng       Date:  2016-02       Impact factor: 5.163

4.  ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer.

Authors:  Paulina Orzol; Marta Nekulova; Jitka Holcakova; Petr Muller; Borivoj Votesek; Philip J Coates
Journal:  Tumour Biol       Date:  2016-01-29

5.  Topography of epithelial-mesenchymal plasticity.

Authors:  Francesc Font-Clos; Stefano Zapperi; Caterina A M La Porta
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-21       Impact factor: 11.205

6.  KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.

Authors:  A T Alshareeda; O H Negm; A R Green; C C Nolan; P Tighe; N Albarakati; R Sultana; S Madhusudan; I O Ellis; E A Rakha
Journal:  Br J Cancer       Date:  2015-05-19       Impact factor: 7.640

7.  Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.

Authors:  Dena A J Ahmad; Ola H Negm; M Layth Alabdullah; Sameer Mirza; Mohamed R Hamed; Vimla Band; Andrew R Green; Ian O Ellis; Emad A Rakha
Journal:  Breast Cancer Res Treat       Date:  2016-09-03       Impact factor: 4.872

Review 8.  Epithelial-mesenchymal transition in tumor metastasis.

Authors:  Kay T Yeung; Jing Yang
Journal:  Mol Oncol       Date:  2016-12-09       Impact factor: 6.603

9.  Treatment of Human Placental Choriocarcinoma Cells with Formaldehyde and Benzene Induced Growth and Epithelial Mesenchymal Transition via Induction of an Antioxidant Effect.

Authors:  Hae-Miru Lee; Soo-Min Kim; Kyung-Chul Choi
Journal:  Int J Environ Res Public Health       Date:  2017-07-29       Impact factor: 3.390

Review 10.  Epithelial-Mesenchymal Transition and Breast Cancer.

Authors:  Yanyuan Wu; Marianna Sarkissyan; Jaydutt V Vadgama
Journal:  J Clin Med       Date:  2016-01-26       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.